384 related articles for article (PubMed ID: 17338926)
1. Pathology of pulmonary hypertension.
Tuder RM; Marecki JC; Richter A; Fijalkowska I; Flores S
Clin Chest Med; 2007 Mar; 28(1):23-42, vii. PubMed ID: 17338926
[TBL] [Abstract][Full Text] [Related]
2. Pathology and pathobiology of pulmonary hypertension.
Guignabert C; Dorfmuller P
Semin Respir Crit Care Med; 2013 Oct; 34(5):551-9. PubMed ID: 24037624
[TBL] [Abstract][Full Text] [Related]
3. Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implications.
Michelakis ED
Circ Res; 2006 Feb; 98(2):172-5. PubMed ID: 16456109
[No Abstract] [Full Text] [Related]
4. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
5. Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children.
Hall S; Brogan P; Haworth SG; Klein N
Thorax; 2009 Sep; 64(9):778-83. PubMed ID: 19525266
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular pathobiology of pulmonary hypertension conference summary.
Rabinovitch M
Chest; 2005 Dec; 128(6 Suppl):642S-646S. PubMed ID: 16373886
[No Abstract] [Full Text] [Related]
7. Cellular and molecular basis of pulmonary arterial hypertension.
Morrell NW; Adnot S; Archer SL; Dupuis J; Lloyd Jones P; MacLean MR; McMurtry IF; Stenmark KR; Thistlethwaite PA; Weissmann N; Yuan JX; Weir EK
J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S20-S31. PubMed ID: 19555855
[TBL] [Abstract][Full Text] [Related]
8. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
[TBL] [Abstract][Full Text] [Related]
9. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
Kayikçioğlu M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
[TBL] [Abstract][Full Text] [Related]
10. Mediators involved in HIV-related pulmonary arterial hypertension.
Humbert M
AIDS; 2008 Sep; 22 Suppl 3():S41-7. PubMed ID: 18845921
[TBL] [Abstract][Full Text] [Related]
11. Pathobiology of pulmonary hypertension.
Rabinovitch M
Annu Rev Pathol; 2007; 2():369-99. PubMed ID: 18039104
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular pathobiology of pulmonary arterial hypertension.
Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
[TBL] [Abstract][Full Text] [Related]
13. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
Wang Y; Zhang XH; Wang HL
Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
[TBL] [Abstract][Full Text] [Related]
14. Interaction between bone morphogenetic proteins and endothelin-1 in human pulmonary artery smooth muscle.
Din S; Sarathchandra P; Yacoub MH; Chester AH
Vascul Pharmacol; 2009; 51(5-6):344-9. PubMed ID: 19786120
[TBL] [Abstract][Full Text] [Related]
15. The cancer paradigm of severe pulmonary arterial hypertension.
Rai PR; Cool CD; King JA; Stevens T; Burns N; Winn RA; Kasper M; Voelkel NF
Am J Respir Crit Care Med; 2008 Sep; 178(6):558-64. PubMed ID: 18556624
[TBL] [Abstract][Full Text] [Related]
16. Current insights on the pathogenesis of pulmonary arterial hypertension.
Perros F; Dorfmüller P; Humbert M
Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein 4 promotes vascular remodeling in hypoxic pulmonary hypertension.
Frank D; Johnson J; de Caestecker M
Chest; 2005 Dec; 128(6 Suppl):590S-591S. PubMed ID: 16373851
[No Abstract] [Full Text] [Related]
18. Endothelial progenitor cells in pulmonary arterial hypertension.
Diller GP; Thum T; Wilkins MR; Wharton J
Trends Cardiovasc Med; 2010 Jan; 20(1):22-9. PubMed ID: 20685574
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension: physiologic or pathologic disease?
Soifer SJ
Crit Care Med; 1993 Sep; 21(9 Suppl):S370-4. PubMed ID: 8365235
[No Abstract] [Full Text] [Related]
20. Pulmonary arterial hypertension: a look to the future.
Rubin LJ; Galiè N
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):89S-90S. PubMed ID: 15194184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
